The sequential therapy regimen for Helicobacter pylon eradication: a pooled-data analysis

Zullo, Angelo; de Francesco, Vincenzo; Hassan, Cesare; Morini, Sergio; Vaira, Dino
October 2007
Gut;Oct2007, Vol. 56 Issue 10, p1353
Academic Journal
Background: Standard triple therapies are the most used treatment in clinical practice. However, a critical fall in the H pylon eradication rate following these therapies has been observed in the last few years. The sequential regimen is a novel, promising therapeutic approach. Objectives: To evaluate the available data on the sequential therapy regimen. Methods: A pooled-data analysis of all studies on the sequential regimen was performed. The eradication rate was calculated according to gastroduodenal pathology, proton pump inhibitor used, antibiotic resistance, as well as setting (paediatric or geriatric patients). Compliance, side effects, and cost implications were also evaluated. Results: Overall, more than 1 800 patients have been treated with the sequential regimen. Such a therapy was superior to 7-10 days triple therapies in paediatric, adult and elderly patients, achieving an eradication rate constantly higher than 90% at ITT analysis. Although primary clarithromycin resistance reduced the efficacy of such a therapy, a success rate significantly higher than that observed with the standard 7-10 days triple therapies was found. Conclusion: The 10-day sequential treatment regimen achieves higher eradication rates than standard triple therapies.


Related Articles

  • PPIs, H. pylori, and Atrophic Gastritis: Putting the Issue to Rest? DiBaise, John K.; Thompson, Jon S. // American Journal of Gastroenterology;Dec1999, Vol. 94 Issue 12, p3403 

    Discusses research being done on the effect of acid suppression therapy on the development of atrophic gastritis in individuals infected with Helicobacter pylori. Reference to a study by L. Lundell, P. Miettinen, H. E. Myrvold et al., published in the 1999 issue of the "American Journal of...

  • 7 days of triple therapy good for H pylon.  // Journal of Family Practice;Jan2008, Vol. 57 Issue 1, p8 

    The article presents synopsis of a study on the optimum duration of treatment for Helicobacter pylori (H pylori) eradication. Meta-analysis on the different durations of triple therapy for H pylori eradication is conducted. Researchers looked through 3 databases and searched conference...

  • CPD TIP OF THE MONTH.  // Pulse;Feb2016, p15 

    The article offers tips when testing a patient with symptoms of dyspepsia, a condition of impaired digestion for Helicobacter pylori including two weeks washout period of proton-pump inhibitor (PPI) before testing, stool antigen test and breath test.

  • Effects of esomeprazole on activity of gastritis in Helicobacter infected patients with gastro-oesophageal reflux disease — an analysis based on the ProGERD study initiative. Vieth, M.; Leodolter, A.; Kulig, M.; Lindner, D.; Jaspersen, D.J.; Labenz, J.; Meyer-Sabellek, W.M.S.; Willich, S.N.; Lind, T.; Malfertheiner, P.; Stolte, M. // Gut;Sep2002 Supplement 2, Vol. 51, pA66 

    Aim: Acid inhibitory treatment is known to aggravate the activity of corpus gastritis in Helicobacter pylori (Hp+) positive patients. However, proton pump inhibitors (PPI) suppress the Hp colonisation in the antrum and improve antrum gastritis in Hp infected patients. This study investigated the...

  • Proton pump inhibitors versus H[sub 2] antagonists. Meta-analysis of its efficacy with antibiotics on Helicobacter pylori eradication. Gisbert, J.P.; Khorrami, S.; Calvet, X.; Gabriel, R.; Carballo, F.; Carmona, L.; Roque, M.; Pajares, J.M. // Gut;Sep2002 Supplement 2, Vol. 51, pA93 

    Aim: It is unknown whether proton pump inhibitors (PPIs) are superior to H[sub 2] antagonists (H[sub 2]-antag) in H. pylori eradication regimens. Our aim was to perform a meta-analysis comparing the efficacy of both antisecretors when co-prescribed with antibiotics. Methods: Selection criteria:...

  • Intravenous omeprazole acts more rapidly in H. pylori positve patients with peptic ulcer bleeding. Leodolter, A.; Glasbrenner, B.; Peitz, U.; Treiber, G.; Kahl, S.; Malfertheiner, P. // Gut;Sep2002 Supplement 2, Vol. 51, pA94 

    Intravenous proton pump inhibitor (PPI) therapy is the standard medical therapy in conjunction with endoscopic intervention for patients with peptic ulcer bleeding. PPI's are more effective in H. pylori positive patients, but up to now this effect has been observed following an extended period...

  • Recent Advances in the Treatment of Helicobacter pylori Infection. Bergamaschi, Antonio; Magrini, Andrea; Pietroiusti, Antonio // Recent Patents on Anti-Infective Drug Discovery;Nov2007, Vol. 2 Issue 3, p197 

    The approach to the treatment of Helicobacter pylori infection has changed during the last years. In fact, during the last decade, the success rate of usual eradication regimens, based on a proton pump inhibitor plus clarithromycin associated with amoxicillin or metronidazole, declined from over...

  • H. pylori Treatment: New Wine in Old Bottles? Vakil, Nimish // American Journal of Gastroenterology;Jan2009, Vol. 104 Issue 1, p26 

    Treatment of Helicobacter pylori infection has become a problem in many clinical settings. Eradication rates are at the lowest levels seen in the past decade and are likely to fall further as antimicrobial resistance becomes more prevalent worldwide. Culture of H. pylori and antimicrobial...

  • Is Furazolidone Therapy for Helicobacter pylori Effective and Safe? Francesco, Vincenzo; Ierardi, Enzo; Hassan, Cesare; Zullo, Angelo // Digestive Diseases & Sciences;Oct2009, Vol. 54 Issue 10, p2298 

    The article presents the author's perspectives on the study regarding the efficacy and safety of furazolidone therapy for Helicobacter pylori infection. The author states that the reported side-effects incidence in the study would seem much higher than that discovered accompanying a simpler...


Read the Article


Sign out of this library

Other Topics